References
- Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951; 27: 277–294
- Noth I, Strek M E, Leff A R. Churg–Strauss syndrome. Lancet 2003; 361: 587–594
- Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, et al. Prognostic factors in polyarteritis nodosa and Churg–Strauss syndrome. A prognostic study in 342 patients. Medicine 1996; 75: 17–28
- Wechsler M E, Garpestad E, Flier S R, Kocher O, Weiland D A, et al. Pulmonary infiltrates, eosinophilia and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998; 279: 455–457
- Wechsler M E, Finn D, Gunawardena D, Westlake R, Barker A, et al. Churg–Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000; 117: 708–713
- Tuggey J M, Hosher H SR. Churg–Strauss syndrome associated with montelukast therapy. Thorax 2000; 55: 805–806
- Guilpain P, Viallard J F, Lagarde P, Cohen P, Kambouchner M, et al. Churg–Strauss syndrome in two patients receiving montelukast. Rheumatology 2002; 41: 535–539
- Solans R, Bosch J A, Selva A, Orriols R, Vilardell M. Montelukast and Churg–Strauss syndrome. Thorax 2002; 57: 183–185
- Conen D, Leuppi J, Bubendorf L, Ronsdorf A, Tamm M, Hauser T. Montelukast and Churg–Strauss syndrome. Swiss Med Wkly 2004; 134: 377–380
- Guillevin L, Cohen P, Gayraud M, et al. Churg–Strauss syndrome: clinical study and long up of 96 patients. Medicine 1999; 78: 26–37
- Lynch K R, O'Neill G P, Lin Q, et al. Characterisation of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999; 399: 789–793
- Kinoshita M, Shiraishi T, Koga T, et al. Churg–Strauss syndrome after corticosteoid therapy with asthmatic treated with pranlukast. J Allergy Clin Immunol 1999; 103: 534–535
- Franco J, Arte′ M. Pulmonary eosinophilia associated with montelukast. Thorax 1999; 54: 558–560
- DuMouchel W, Smith E T, Beasley R, Nelson H, Yang X, Fram D, Almenoff J S. Association of asthma therapy and Churg–Strauss syndrome: An analysis of postmarketing surveillance data. Clinical Therapeutics 2004; 26: 1092–1104
- Munoz N M, Douglas I, Mayer D, Herrnreiter A, Zhu X, Leff A R. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. Am J Resp Crit Care Med 1997; 155: 1398–1403
- Keogh K A, Specks U. Churg–Strauss syndrome: Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003; 115: 284–290
- Mukhopadhyay A, Stanley N N. Churg–Strauss syndrome associated with montelukast. Postgrad Med J 2001; 77: 390–391